Entyce Oral Suspension 30mg/ml 15ml

Entyce Oral Suspension 30mg/ml 15ml
Entyce Oral Suspension 30mg/ml 15ml
View Images
  • There are no alternate images available for this product.
 

Entyce Oral Suspension 30mg/ml 15ml

  • Manufacturers :

 

Product Description

 

Product Details
Entyce® Oral Suspension 
 
Product Information
ENTYCE® (capromorelin oral solution) is the only FDA-approved therapeutic designed to safely and effectively stimulate appetite in dogs. ENTYCE works by mimicking ghrelin (the "hunger hormone"). Administered orally once a day, ENTYCE is appropriate to treat inappetence caused by chronic and acute conditions.
Entyce is a selective ghrelin receptor agonist that binds to receptors that stimulate appetite. A laboratory study conducted with Entyce showed an increased appetite in normal healthy dogs. In a clinical trial, Entyce was proven effective in dogs with a reduced or no appetite due to various underlying medical conditions. Good appetite and nutrition help support overall health and are important factors a veterinarian considers when managing disease conditions in dogs. The side effects of Entyce include diarrhea, vomiting, increased thirst, and increased salivation. The drug should be used with caution in dogs with liver or kidney problems.
Entyce must be prescribed by a licensed veterinarian because professional expertise is needed to diagnose and manage decreased appetite in dogs and to monitor patients for possible adverse effects of the drug.
ENTYCE® (capromorelin oral solution) is a ghrelin receptor agonist that mimics the effect of ghrelin (the "hunger hormone"). Like naturally occurring ghrelin, ENTYCE binds to specific cell receptors and affects signaling in the hypothalamus, causing the feeling of hunger.
 
For
Dogs
 
Benefits
The therapeutic provides a convenient, once-daily oral solution for treating inappetence. 
 
Active Ingredients
Carprofen
 
Side Effects
Adverse reactions in dogs may include diarrhea, vomiting, polydipsia, and hypersalivation. 
 
Usage
Recommended Dose:
3 mg/kg (1.4 mg/lb) body weight once daily
To administer ENTYCE, the bottle should be shaken gently and then the appropriate amount of solution withdrawn using the provided syringe. The syringe should be rinsed between doses.
 
Cautions
Do not use in breeding, pregnant or lactating dogs. Use with caution in dogs with hepatic dysfunction or renal insufficiency. Should not be used in dogs that have a hypersensitivity to capromorelin.
 
 
 
 

Close